AMY PUHL: Open Payments
NPI 1861957532 · LEWISTON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 16 payments from 5 companies in 2025. Trend: 2023 $459 · 2024 $533 · 2025 $351
Food & beverage: $266Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $260 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Ardelyx, Inc. | 2 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: TREMFYA, DUPIXENT, IBSRELA, IQIRVO, EOHILIA.
Industry payments across ID — which companies pay providers there.
